Ambassador George Hara

Chairman of the Board, Alliance Forum Foundation
(a 501(c)3 non-profit organization in Special Consulting
Status with the UN Economic and Social Council)

Chairman, World Cancer Eradication Summit

Honorary Professor, Faculty of Medicine, The Chinese University of Hong Kong 

Special Advisor, HKSTP, Government of Hong Kong

Mr. Albert Wong

CEO, Hong Kong Science & Technology Parks Corporation

Dr. Grace Lau

Head of Institute for Translational Research,

Hong Kong Science & Technology Parks Corporation

Biomedical Technology Translation in Hong Kong

Prof. Hideyuki Okano

Chairman, Department of Physiology, Keio University School of Medicine, Japan;

President of The Japanese Society for Regenerative Medicine (JSRM)

iPSCs-based Regenerative Medicine
and Drug development for CNS diseases

Professor. Shin KAWAMATA

Director, R&D Center for Cell Therapy at the FBRI (Kobe, Japan);

Regional Executive Committee of International Society for Cell & Gene Therapy (ISCT)

Prof. Masahiro KINO-OKA

Director of Research Base for Cell Manufacturability,
TechnoArena, Graduate School of Engineering,
Osaka University

Robotic automation for cell manufacturing

Prof. Qizhou Lian

GMP Facility for Stem Cell and Gene Therapy,
Stem Cells and Regenerative Medicine Consortium,
The University of Hong Kong

Application of Human Pluripotent Stem Cells for COVID-19
Research and Lung Regeneration

Professor. Atsushi Miyajima

Institute for Quantitative Biosciences, The University of Tokyo

Professor. Takahiro Ochiya

Molecular and Cellular Medicine, Tokyo Medical University

President of Japanese Society for Extracellular Vesicles (JSEV)

Extracellular vesicles from human
hepatic progenitor cells towards
anti-fibrotic therapy

Prof. Pentao LIU

Director, Centre for Translational Stem Cell Biology, Health@InnoHK

School of Biomedical Sciences, LKS Faculty of Medicine,

The University of Hong Kong

Expanded Potential Stem Cells: A New Tool for Basic
and Translational Research

Prof. Guangjin PAN

Centre Co-Director, Centre for Regenerative Medicine and Health,
HK Institute of Science & Innovation,
Chinese Academy of Science

Human Pluripotent Stem Cells in
Clinical Application Purposes

Professor. Godfrey Chan

Chief of Service of Department of Paediatrics,

The Hong Kong Children’s Hospital,

HKU-Shenzhen Hospital & Gleneagles Hospital Hong Kong

Professor. Hung Fat Tse

Chief of Cardiology Division, Department of Medicine,
LKS Faculty of Medicine, The University of Hong Kong

Future Prospective of Cell-Based Regenerative Therapy

Professor. Ling QIN

Director of CUHK SZ-HK Innovation Technology Institute (Futian) and
Musculoskeletal Research Laboratory, Department of Orthopaedics &
Traumatology, The Chinese University of Hong Kong

Seeking Biodegradable Metals for Developing Class III
Medical Implants for Clinical Applications

Professor. Shoichi Maruyama

Department of Nephrology, Nagoya University Graduate School of
Medicine, Nagoya University
Vice-President of Nagoya University Hospital

Mesenchymal stem cell therapy for refractory IgA
nephropathy

Dr. Eddie Sun

Strategic Alliance Manager, Thermo Fisher Scientific

Transition your PSC research to clinic and manufacturing

Professor. Rocky S. Tuan

Vice-Chancellor and President,

The Chinese University of Hong Kong

Mr. Kunio Yamada 

Chairman & CEO, Rohto Pharmaceutical Co., Ltd